Cargando…

(18)F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study

BACKGROUND: Positron emission tomography/computed tomography (PET/CT) using radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in biochemical recurring prostate cancer. The aim of our study was to assess the usefulness of (18)F-JK-PSMA-7 PET/CT for local and nodal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vierasu, Irina, Van Simaeys, Gaetan, Trotta, Nicola, Lacroix, Simon, Bormans, Guy, Albisinni, Simone, Quackels, Thierry, Roumeguère, Thierry, Goldman, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868215/ https://www.ncbi.nlm.nih.gov/pubmed/36683076 http://dx.doi.org/10.1186/s41824-022-00161-2

Ejemplares similares

Clinical experience with (18)F-JK-PSMA-7 when using a digital PET/CT
por: Vierasu, Irina, et al.
Publicado: (2022)

Validated Prospective Assessment of Quality of Life After Robot-Assisted Laparoscopic Prostatectomy: Beyond Continence and Erections
por: Albisinni, Simone, et al.
Publicado: (2019)

Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical Prostatectomy
por: Leplat, Charles, et al.
Publicado: (2023)

Isolated non-ascitic peritoneal carcinomatosis after robotic radical prostatectomy for prostate cancer: A case report
por: El khoury, Michael-Abdo-Jefferson Billy, et al.
Publicado: (2020)

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer
por: Holz, Serge, et al.
Publicado: (2017)

Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic
por: Diamand, Romain, et al.
Publicado: (2020)

Current Imaging Techniques for Lymph Node Staging in Prostate Cancer: A Review
por: Muteganya, Raoul, et al.
Publicado: (2018)

Voxelwise Principal Component Analysis of Dynamic [S-Methyl-(11)C]Methionine PET Data in Glioma Patients
por: Martens, Corentin, et al.
Publicado: (2021)

[(18)F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
por: Dietlein, Felix, et al.
Publicado: (2020)

Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates
por: Rosenzweig, Barak, et al.
Publicado: (2022)

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021)

JK
por: Marwaha, Seema
Publicado: (2021)

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2018)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative (68)Ga-PSMA-11 PET/CT
por: Qiu, Xuefeng, et al.
Publicado: (2021)

(68)Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
por: Yuminaga, Yuigi, et al.
Publicado: (2021)

Evaluation of (18)F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
por: Zhou, Xing, et al.
Publicado: (2021)

Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients
por: Bondue, Benjamin, et al.
Publicado: (2019)

J.K. Rowling vista por J.K. Rowling /
por: Fraser, Lindsey
Publicado: (2001)

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy
por: Mapelli, Paola, et al.
Publicado: (2023)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
por: Champion, Ambroise, et al.
Publicado: (2023)

Cancer de Prostate, déprivation androgénique, et risques d’infection par la COVID-19 : revue systématique et méta-analyse
por: Manolache, Narcis-Georges, et al.
Publicado: (2022)

Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model?
por: Martens, Corentin, et al.
Publicado: (2022)

Oligometastatic Disease Detection with (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
por: Artigas, Carlos, et al.
Publicado: (2021)

Detection Efficacy of (18)F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
por: Giesel, Frederik L., et al.
Publicado: (2019)

Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy
por: Bashir, Usman, et al.
Publicado: (2019)

Changes of Radiation Treatment Concept Based on (68)Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
por: Bottke, Dirk, et al.
Publicado: (2021)

False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
por: Orevi, Marina, et al.
Publicado: (2022)

PSMA-PET detected port site recurrence of prostate cancer following minimally invasive radical prostatectomy and utilisation of hookwire localisation for excision
por: Harrison, William, et al.
Publicado: (2023)

Biodistribution and radiation dosimetry of [(18)F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer
por: Hohberg, Melanie, et al.
Publicado: (2019)

Bilateral cytomegalovirus infection of the adrenal glands revealed by (18)F‐FDG PET/CT in a patient with T‐cell lymphoma
por: Van Bogaert, Camille, et al.
Publicado: (2022)

New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives
por: Albisinni, Simone, et al.
Publicado: (2016)

(68)Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
por: Grubmüller, B., et al.
Publicado: (2017)

Improved oncological outcome after radical prostatectomy in patients staged with (68)Ga-PSMA-11 PET: a single-center retrospective cohort comparison
por: Ferraro, Daniela A., et al.
Publicado: (2020)

Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review
por: Nabian, Naeim, et al.
Publicado: (2022)

Head-to-Head Comparison of (68)Ga-PSMA-11 PET/CT and Multiparametric MRI for Pelvic Lymph Node Staging Prior to Radical Prostatectomy in Patients With Intermediate to High-Risk Prostate Cancer: A Meta-Analysis
por: Wang, Xueju, et al.
Publicado: (2021)

COVID-19 and BCG: where’s the challenge?
por: Mjaess, Georges, et al.
Publicado: (2021)

Predictors of trainees’ proficiency during the learning curve of robot-assisted radical prostatectomy at high- -volume institutions: results from a multicentric series
por: Anceschi, Umberto, et al.
Publicado: (2023)

(68)Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy
por: Li, Teng-Cheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sicppnuj3dkpp0j1l8pcmfm383